- Report
- February 2024
- 120 Pages
Asia Pacific
From €4778EUR$4,950USD£4,098GBP
- Report
- April 2024
- 250 Pages
Global
From €3856EUR$3,995USD£3,308GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- March 2024
- 199 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 355 Pages
Global
From €5260EUR$5,450USD£4,512GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- February 2024
- 175 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- January 2024
- 148 Pages
Global
From €3763EUR$3,899USD£3,228GBP
- Report
- November 2023
- 147 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- November 2023
- 138 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- June 2023
- 165 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- January 2024
- 200 Pages
Global
From €4006EUR$4,150USD£3,436GBP
- Report
- January 2024
- 120 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- January 2022
- 197 Pages
Global
From €6544EUR$6,780USD£5,613GBP
- Report
- August 2022
- 115 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- February 2019
United States
From €4339EUR$4,495USD£3,722GBP
Crohn's Disease is a chronic inflammatory condition of the gastrointestinal tract, primarily affecting the small and large intestine. It is a type of Inflammatory Bowel Disease (IBD) and is characterized by abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. Symptoms can range from mild to severe and can be managed with medications, lifestyle changes, and in some cases, surgery.
The Crohn's Disease market within the context of Gastroenterology is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global market for Crohn's Disease treatments will reach $7.5 billion by 2027. The market is driven by the increasing prevalence of the disease, the development of new treatments, and the growing awareness of the condition.
Companies in the Crohn's Disease market include AbbVie, Pfizer, Janssen, Takeda, and Celgene. These companies are involved in the development and marketing of treatments for Crohn's Disease, including biologics, small molecules, and other therapies. Show Less Read more